XD

Xinghua Dingli

Description

Xinghua Dingli is an investment company.

Investor Profile

Xinghua Dingli has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xinghua Dingli frequently co-invest with?

Co-Investments: 1
Conswall Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HK
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Dongfang Jiafu
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Haibang Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Yinxinggu Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
HT Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Haitong Capital
Europe, Lisboa, Portugal, Lisbon
Co-Investments: 1

What are some of recent deals done by Xinghua Dingli?

Healsun Biopharm

Hangzhou, Zhejiang, China

Healsun Biopharm is a Biopharmaceutical company that focuses on antibody/recombinant protein CRO/CDMO

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BAug 19, 2022
Amount Raised: $36,672,485